Invesco Ltd. Neogenomics Inc Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Neogenomics Inc stock. As of the latest transaction made, Invesco Ltd. holds 438,756 shares of NEO stock, worth $7.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

438,756

Previous 481,187 8.82%

Holding current value

$7.7 Million

Previous $6.67 Million 3.04%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$13.4 - $17.73 $568,575 - $752,301	-42,431 Reduced 8.82%	438,756 $6.47 Million
Q2 2024 Aug 13, 2024	SELL	$13.01 - $15.77 $468,151 - $567,467	-35,984 Reduced 6.96%	481,187 $6.67 Million
Q1 2024 May 14, 2024	SELL	$14.06 - $16.79 $16.6 Million - $19.8 Million	-1,177,288 Reduced 69.48%	517,171 $8.13 Million
Q4 2023 Feb 12, 2024	SELL	$11.67 - $20.73 $754,768 - $1.34 Million	-64,676 Reduced 3.68%	1,694,459 $27.4 Million
Q3 2023 Nov 13, 2023	BUY	$12.15 - $17.85 $536,787 - $788,613	44,180 Added 2.58%	1,759,135 $21.6 Million
Q2 2023 Aug 11, 2023	SELL	$14.1 - $19.83 $2.05 Million - $2.88 Million	-145,483 Reduced 7.82%	1,714,955 $27.6 Million
Q1 2023 May 12, 2023	BUY	$9.09 - $19.45 $11.5 Million - $24.7 Million	1,267,937 Added 214.0%	1,860,438 $32.4 Million
Q4 2022 Feb 13, 2023	SELL	$6.45 - $12.07 $4.67 Million - $8.74 Million	-723,792 Reduced 54.99%	592,501 $5.47 Million
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $186,714 - $306,677	-23,755 Reduced 1.77%	1,316,293 $11.3 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $93,184 - $184,390	13,199 Added 0.99%	1,340,048 $10.9 Million
Q1 2022 May 16, 2022	SELL	$12.15 - $35.28 $29.4 Million - $85.4 Million	-2,421,774 Reduced 64.6%	1,326,849 $16.1 Million
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $7.91 Million - $12.6 Million	-259,341 Reduced 6.47%	3,748,623 $128 Million
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $20.2 Million - $25.5 Million	-485,987 Reduced 10.81%	4,007,964 $193 Million
Q2 2021 Aug 17, 2021	SELL	$36.62 - $51.69 $12.1 Million - $17.1 Million	-330,014 Reduced 6.84%	4,493,951 $203 Million
Q1 2021 May 17, 2021	SELL	$41.56 - $59.88 $23.6 Million - $34 Million	-567,602 Reduced 10.53%	4,823,965 $233 Million
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $8.77 Million - $13.7 Million	243,036 Added 4.72%	5,391,567 $290 Million
Q3 2020 Nov 16, 2020	BUY	$33.26 - $40.48 $25.8 Million - $31.4 Million	774,895 Added 17.72%	5,148,531 $190 Million
Q2 2020 Aug 14, 2020	BUY	$24.21 - $31.02 $12.4 Million - $15.9 Million	511,828 Added 13.25%	4,373,636 $135 Million
Q1 2020 May 15, 2020	BUY	$20.5 - $34.53 $32.1 Million - $54.1 Million	1,565,935 Added 68.21%	3,861,808 $107 Million
Q4 2019 Feb 14, 2020	BUY	$18.96 - $29.84 $16.1 Million - $25.4 Million	851,060 Added 58.9%	2,295,873 $67.2 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $900,016 - $1.24 Million	-47,072 Reduced 3.16%	1,444,813 $27.6 Million
Q2 2019 Aug 14, 2019	SELL	$19.57 - $24.1 $2.9 Million - $3.57 Million	-148,170 Reduced 9.03%	1,491,885 $32.7 Million
Q1 2019 May 15, 2019	BUY	$12.14 - $20.46 $18.9 Million - $31.9 Million	1,557,319 Added 1882.27%	1,640,055 $33.6 Million
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $929,952 - $1.53 Million	82,736 New	82,736 $1.04 Million

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.21B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account